GLP-1R agonist (Pukang Weixin Bio)

GLP-1R激动剂(普康唯新)

Report date: 2026/04/13 20:02:18
NME

Base Information

Drug NameGLP-1R agonist (Pukang Weixin Bio)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsCognition DisordersDyspepsiaObesity +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChengdu Pukang Weixin Biotechnology Co., Ltd.
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Pukang Weixin Biotechnology Co., Ltd.
Inactive CompaniesN/A
Active IndicationsCognition DisordersDyspepsiaObesity +[11] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A